Predicting Outcomes, Enhancing Safety
Cytocast Digital Twin Platform™ designed to predict drug candidate side effects by simulating billions of molecular interactions.

How can we help?

Drug Discovery

The Cytocast Digital Twin Platform™ is an innovative platform designed to predict drug side effects by simulating billions of molecular interactions within human cells. Relying on a wide range of available information on how complex cellular processes work, our solution has the potential to revolutionize drug discovery by accelerating the overall process, reducing costs, and increasing clinical trial success rates.

Cytocast Digital Twin Platform™

Precision medicine

Cytocast Digital Twin Patient™ technology is currently in development at Cytocast. It is poised to play a pivotal role in enabling data-driven, personalized care that tailors treatments to patients based on their distinctive molecular characteristics, covering a wide range of therapeutic domains. Our approach to precision medicine development leverages multi-omics, single-cell, and patient data to gain a comprehensive understanding of how perturbations, such as diseases or drugs, impact cellular health in a more personalized manner.

Cytocast Digital Twin Population™

People and Values

Cytocast is an emerging TechBio startup based in Budapest that specializes in data-driven medical technology. We leverage this data to add value and achieve impactful results.

OUR VALUES

We are proud to be a company with a curious mindset and a strong research orientation. What sets us apart is the way we integrate multi-omics data, extensive scientific knowledge, expertise, high-performance computing, and cutting-edge data science methods to maximize insights into patient biology and accelerate the pace of drug discovery and development. We also have the privilege of working with numerous collaborative partners. We value these partnerships and recognize their importance in advancing our mission.

MAKE MEDICINE BETTER WITH ADVANCED CELL SIMULATION TECHNOLOGY

THE TEAM

At Cytocast, we believe in creative solutions and in the power of teamwork in a familiar atmosphere. Many of our team members have university affiliations continually exploring new possibilities.

How we do it

Cytocast is using computer simulations to determine the most effective treatment for patients while minimazing potential side effects

0

Proteins per simulation

0

Protein-protein interactions

0

Binding sites per simulation

0

Nr. of cell types

Blog

TechBio, Biotech, and DeepTech: key differences and why they matter

Technological advancements are reshaping healthcare, biology, and the pharmaceutical industry, yet the terms TechBio, BioTech, and DeepTech are often used interchangeably.

Unlocking the power of computational tools in protein complex prediction

Proteins rarely function in isolation. Interactions between thousands of proteins shape a cell’s PPI network, forming transient or stable complexes.

Unraveling COVID-19’s neurological impacts: Insights into microglial dysfunction and CNS inflammation

A recent study sheds light on the complex molecular and cellular mechanisms underpinning neurological pathologies caused by COVID-19, with a focus on microglial dysfunction and central nervous system (CNS) inflammation.

Interested in a demo?

Contact us today to learn how the CYTOCAST DIGITAL TWIN Platform™ can revolutionize your R&D efforts and bring you closer to breakthroughs in drug safety and efficacy.

Predicting Outcomes, Enhancing SafetyCytocast Digital Twin Platform™ designed to predict drug candidate side effects by simulating billions of molecular interactions.